Tracking Jeremy Grantham's GMO Capital Portfolio - Q3 2022 Update

John Vincent profile picture
John Vincent
22.39K Followers

Summary

  • Jeremy Grantham’s 13F portfolio value decreased from $18.46B to $17.33B this quarter.
  • GMO Capital increased Johnson & Johnson, Meta Platforms, and Teck Resources while reducing Apple.
  • The largest three individual stock positions are Microsoft Corporation, United Health, and Johnson & Johnson, and they add up to ~10% of the portfolio.

University Of Oxford And Its Smith School Of Enterprise And Environment Host ReSource 2012

Matthew Lloyd

This article is part of a series that provides an ongoing analysis of the changes made to GMO’s 13F stock portfolio on a quarterly basis. It is based on GMO’s regulatory 13F Form filed on 11/10/2022. Jeremy Grantham’s

Jeremy Grantham - GMO Capital's Q3 2022 13F Report Q/Q Comparison

Jeremy Grantham - GMO Capital's Q3 2022 13F Report Q/Q Comparison (John Vincent (author))

This article was written by

John Vincent profile picture
22.39K Followers
Focused on cloning strategies by analyzing 13F reports of a curated set of around fifty super-investors and generating Absolute Returns thru exploiting inefficiency, volatility, and momentum.

Disclosure: I/we have a beneficial long position in the shares of AAPL, AMZN, GOOGL, META either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Recommended For You

Comments (6)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.